Cancer Patient Empowerment Program: Phase 2 Feasibility Study
NCT ID: NCT05508412
Last Updated: 2024-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
104 participants
INTERVENTIONAL
2022-12-06
2025-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Dyadic Approach to Cancer Care: a Feasibility and Efficacy Partner-based Exercise Study
NCT05333016
Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer
NCT00037024
The Efficacy of Health Partnership Program for Cancer Patients
NCT01527409
Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial
NCT02939612
Web-based Collaborative Care Intervention Study
NCT02939755
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention with HRV monitor
CancerPEP
CancerPEP
Intervention without HRV monitor
CancerPEP
CancerPEP
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CancerPEP
CancerPEP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of a cancer diagnosis as per the participant's report.
* Safe to exercise and do strength training. Participants who have recovered from a minor stroke or heart condition in the past will require approval from their Family Physician or Cardiologist to participate in the study.
* Participants with advanced cancer (including cancer spread to bones) will need approval from the Study Physician or their Oncologist to participate.
* Existing (or willingness to create) email account and willingness to access email daily.
* Ability to follow website links to watch YouTube videos.
* Ability to understand and speak English.
* Ability to participate in low to moderate levels of physical activity and strength training.
* Ability and willingness to fill out an online survey at baseline, and 6, 12 and possibly 24 months, and a weekly compliance survey for the six months of the program.
* Deemed to have an expected survival greater than 1 year and expected to be well enough to complete the six-month training
Exclusion Criteria
* Unable to access the internet and lack of a computer or smartphone to receive emails required for study intervention, or unable to click on a link to successfully watch a YouTube video.
* Those with a predicted survival less than 1 year, or not expected to be able to participate in the program for six months.
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dalhousie University
OTHER
Nova Scotia Health Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gabriela Ilie
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ilie G, Knapp G, Davidson A, Snow S, Dahn HM, MacDonald C, Tsirigotis M, Rutledge RDH. The Cancer Patient Empowerment Program: A Comprehensive Approach to Reducing Psychological Distress in Cancer Survivors, with Insights from a Mixed-Model Analysis, Including Implications for Breast Cancer Patients. Cancers (Basel). 2024 Oct 2;16(19):3373. doi: 10.3390/cancers16193373.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CancerPEP-Phase2-Protocol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.